# Tocilizumab Effect on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients

> **NCT03149796** · — · COMPLETED · sponsor: **Carmel Medical Center** · enrollment: 80 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** laboratory blood tests

## Key facts

- **NCT ID:** NCT03149796
- **Lead sponsor:** Carmel Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-23
- **Primary completion:** 2013-05-01
- **Final completion:** 2013-05-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03149796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03149796, "Tocilizumab Effect on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03149796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*